BNT (BNT) Stock Price & Analysis
BNT (BNT) rose 3.22% to USD 45.47 as of June 10, 2026 at 05:11 UTC, according to Nexqual real-time market data.
BNT last closed at USD 44.05; the session ranged USD 44.5–45.48 on volume of 20,223 shares. Market capitalization is $12.48B, with a 52-week range of USD 38.43–49.86 (NYQ). Source: Nexqual, June 10, 2026 at 05:11 UTC.
Key Statistics (as of June 10, 2026 at 05:11 UTC)
| Price | USD 45.47 |
|---|---|
| Change | ▲ 3.22% (up) |
| Previous Close | USD 44.05 |
| Open | USD 44.02 |
| Day Range | USD 44.5 – 45.48 |
| 52-Week Range | USD 38.43 – 49.86 |
| Volume | 20,223 shares |
| Market Cap | $12.48B |
| Exchange | NYQ |
Technical Analysis (BNT)
Nexqual's technical model rates BNT "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:11 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 41.62 (neutral) |
| vs SMA50 | Above (USD 44.79) |
| MACD | -0.16 (negative) |
Analyst Ratings (BNT)
Wall Street analysts rate BNT "None", per Nexqual as of June 10, 2026 at 05:11 UTC.
| Consensus Rating | None |
|---|
Earnings (BNT)
| Next Earnings Date | 2026-08-13 |
|---|
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Financials & Fundamentals (BNT)
| Total Revenue | $10.67B |
|---|---|
| Revenue Growth (YoY) | -36.70% |
| Gross Margin | +29.12% |
| Operating Margin | -16.30% |
| Profit Margin | +4.53% |
| ROE | +3.63% |
| Debt / Equity | 51.62 |
| Current Ratio | 2.62 |
| Total Cash | $10.77B |
| Total Debt | $8.72B |
| Free Cash Flow | $8.93B |
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Financial Health Score (BNT)
Nexqual rates BNT's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 05:11 UTC.
| Growth | Critical — Revenue -37% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 29%, operating -16% |
| Balance Sheet | Strong — $10.8B cash vs $8.72B debt, net cash position |
| Cash Flow | Strong — FCF $8.93B, 121% margin |
| Efficiency | Weak — ROE 4%, ROA 0.7% |
Ownership (BNT)
| Insider Ownership | +23.89% |
|---|---|
| Institutional Ownership | +48.02% |
| Shares Outstanding | 59.93M |
| Float | 20.42M |
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Leadership (BNT)
BNT is led by Sachin G. Shah (age 48), CEO, Head of Insurance Solutions Business & Director, per Nexqual as of June 10, 2026 at 05:11 UTC.
| CEO, Head of Insurance Solutions Business & Director | Sachin G. Shah (age 48) |
|---|---|
| Managing Partner & CFO | Thomas Douglas Corbett (age 45) |
| Managing Director | Gregory N. McConnie (age 52) |
| Managing Director of Portfolio Management | Susan Beth Comparato (age 56) |
Major Backers & Investors (BNT)
Notable institutional backers of BNT include Partners Value Investments LP, Brookfield Corp /ON/, Royal Bank of Canada, according to Nexqual as of June 10, 2026 at 05:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Partners Value Investments LP | 18.84% |
| Brookfield Corp /ON/ | 2.07% |
| Royal Bank of Canada | 1.32% |
| Bank of Nova Scotia | 1.09% |
| Principal Financial Group, Inc. | 0.55% |
| Principal Funds, Inc-MidCap Fund | 0.48% |
| Montrusco Bolton Investments Inc. | 0.47% |
| Alberta Investment Management Corp | 0.47% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.64% |
Source: Nexqual, June 10, 2026 at 05:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TRAD | APEX Tech Acquisition Inc. | USD 9.95 | ▲ 0% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
| BCII | BCII Enterprises Inc. | USD 0.01 | ▲ 9.09% |
| EMIS | Emmis Acquisition Corp. | USD 10.15 | ▲ 0.2% |
| CNXS | CONNEXUS CORP | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:11 UTC. This page is informational and not investment advice.